Despite all the care given to this publication of the patient information leaflets and the SPC of the authorized medicines in Belgium, the FAMHP cannot guarantee the completeness and the conformity with the approved data in the context of clinical trials in Belgium.

Don't hesitate to send your remarks or comments to ct.rd@fagg-afmps.be.

The FAMHP declines all liability for any direct or indirect damage resulting from the use of this database. The FAMHP also reminds readers that this information in no way replaces the necessary advice of your doctor or pharmacist for any use of a medicine. The FAMHP gives no guarantee that the information included in this database does not violate the right of the intellectual property.